Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$13.19K$13.19Kderived— vs Q4 2015 Net Income-$912.33K-$912.33KderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$877,829N/M Operating Cash Flowderived-$187,050N/M Free Cash Flowderived-$187,050N/M Margins · derivedOperating margin-6657.8%
Net margin-6919.5%
ended Dec 31, 2016 · filed Mar 22, 2017 · 81 d after period end